Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Pearl Diagnostics
AddedFeb 16, 2024
UpdatedJun 18, 2026
Pearl Diagnostics

Pearl Diagnostics

Seed

Pearl Diagnostics: Innovating early detection diagnostic products for lung infections since 2014.

HQ
Baltimore, MD, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

Pearl Diagnostics develops diagnostic products to enable early detection and prevent lung infections.

It was founded in 2014 in the Johns Hopkins Fast Forward Accelerator in Baltimore, Maryland.

Pearl Diagnostics - Similar Companies

Plasmonic Diagnostics logo

Plasmonic Diagnostics

Breath Diagnostics logo

Breath Diagnostics

Predictive Health Diagnostics Company logo

Predictive Health Diagnostics Company

Prompt Diagnostics logo

Prompt Diagnostics

prompt-dx.com

NAT Diagnostics logo

NAT Diagnostics

Smart Diagnostics Systems logo

Smart Diagnostics Systems

Test Diagnostics logo

Test Diagnostics

FYR Diagnostics logo

FYR Diagnostics

fyrdiagnostics.com

Accelevir Diagnostics logo

Accelevir Diagnostics

Burst Diagnostics logo

Burst Diagnostics

burst-dx.com

Instadiagnostics logo

Instadiagnostics

Cleveland Diagnostics logo

Cleveland Diagnostics

clevelanddx.com

PLC Diagnostics logo

PLC Diagnostics

BioAmp diagnostics logo

BioAmp diagnostics

bioampdx.com

Amplified Sciences logo

Amplified Sciences

Pearl Diagnostics - Quick Facts

Who are Pearl Diagnostics' competitors?

Companies similar to Pearl Diagnostics include Plasmonic Diagnostics, Breath Diagnostics, Predictive Health Diagnostics Company and Prompt Diagnostics.

When was Pearl Diagnostics founded?

Pearl Diagnostics was founded in 2014.

Where is Pearl Diagnostics' headquarters located?

Pearl Diagnostics' headquarters is located in Baltimore, MD, US.

When was Pearl Diagnostics' last funding round?

Pearl Diagnostics' most recent funding round was for $3.5M (USD) in July 2022.

How much has Pearl Diagnostics raised to-date?

As of Jul 20, 2022, Pearl Diagnostics has raised a total of $3.5M (USD).

How many employees does Pearl Diagnostics have?

Pearl Diagnostics has 7 employees as of Feb 5, 2024.

Pearl Diagnostics - Classification

Ownership
  • Venture Capital
Technology
  • Analytics
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Government
Main Product
  • Diagnostic Products
Tags
  • Biotech
  • Data Information
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 17 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 330000Manufacturing
  • 325000Chemical Manufacturing
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 325410Pharmaceutical and Medicine Manufacturing
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 5000Wholesale Trade-durable Goods
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 5040Professional And Commercial Equipment And Supplies
  • 8730Research, Development, And Testing Services
  • 5047Medical, Dental, And Hospital Equipment And Supplies
  • 8731Commercial Physical and Biological Research